Qiagen NV (QGEN.DE)

QGEN.DE on Xetra

11:35am EDT
Change (% chg)

€-0.56 (-2.38%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for QGEN.DE


QIAGEN N.V. (QIAGEN) is a Netherlands-based holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Sample to... (more)


Beta: 0.46
Market Cap(Mil.): €5,443.19
Shares Outstanding(Mil.): 232.74
Dividend: --
Yield (%): --


  QGEN.DE Industry Sector
P/E (TTM): 59.47 69.55 36.12
EPS (TTM): 0.40 -- --
ROI: 2.59 0.51 14.76
ROE: 3.98 0.43 15.63
Search Stocks

BRIEF-Qiagen sees FY adj EPS at $1.16-$1.18

* Q2 adjusted net income $60.9 million versus reuters poll average $59.5 million

29 Jul 2015

Qiagen Q1 profit down 4 pct on strong dollar, lower HPV test sales

FRANKFURT, May 5 - German genetic tests maker Qiagen NV reported a 4 percent fall in adjusted quarterly net profit as U.S. sales of its human papillomavirus (HPV) test declined and the dollar strengthened, eroding the value of revenues in Europe.

05 May 2015

BRIEF-Qiagen Marseille announces public tender offer by Qiagen NV

* Announces public tender offer on the shares of Qiagen Marseille SA

16 Apr 2015

BRIEF-Qiagen says board member Brandt to run for final 1-yr term

* Says Werner Brandt to stand for re-election for a final one-year term as Qiagen supervisory board member

02 Apr 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Stock Traders Daily
Provider : New Constructs, LLC
Provider : ValuEngine, Inc.
Provider : S&P Capital IQ – STARS Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks